Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.43
-0.05 (-3.38%)
At close: Aug 15, 2025, 3:59 PM
1.47
3.14%
After-hours: Aug 15, 2025, 07:58 PM EDT
Galmed Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.1M | -3.21M | -1.91M | -1.12M | -1.27M | -2.02M | -1.47M | -1.59M | -1.83M | -2.64M | -5.35M | -3.73M | -6.14M | -7.45M | -7.71M | -8.4M | -8.9M |
Depreciation & Amortization | n/a | n/a | n/a | 74K | 9K | 6K | 8K | 9K | 8K | 9K | 8K | 9K | 9K | 10K | 11K | 10K | 11K |
Stock-Based Compensation | 101K | 116K | 132K | 130K | 153K | 195K | 226K | 174K | 297K | 182K | 211K | 446K | 457K | 369K | 574K | 472K | 471K |
Other Working Capital | -366K | -300K | 821K | -31K | -448K | 298K | -361K | 328K | 258K | 373K | -694K | -196K | 95K | 438K | -1.45M | 389K | 348K |
Other Non-Cash Items | -23K | 1.7M | 49K | -10K | 442K | -564K | 3K | 158K | -134K | 240K | 51K | 28K | 166K | 6K | 14K | -3K | -4K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 488K | 86K | -317K | n/a | n/a | n/a | n/a | n/a | 1K | -24K | 71K | 36K |
Change in Working Capital | -141K | -580K | 669K | -92K | -718K | 993K | -1.03M | 202K | -36K | -1.82M | 1.97M | -2.66M | 59K | 76K | -1.85M | 215K | -895K |
Operating Cash Flow | -1.17M | -1.97M | -1.06M | -1.02M | -1.83M | -898K | -2.18M | -1.37M | -1.7M | -4.02M | -3.11M | -5.91M | -5.45M | -6.99M | -8.98M | -7.63M | -9.29M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | -3K | n/a | -1K | -2K | -7K | -1K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.03M | -3.04M | -1.82M | -234K | -1.27M | -907K | -4.86M | -2.83M | -1.14M | -3.62M | -255K | n/a | n/a | -1.5M | -4.24M | 2.18M | -10.01M |
Sales Maturities Of Investments | 801K | -263K | 2.44M | 1.63M | 1.71M | -214K | 1.32M | 5.03M | 2.49M | 21.44M | -10.46M | 4.15M | 6.31M | 7.89M | 8.79M | n/a | 8.36M |
Other Investing Acitivies | n/a | -250K | n/a | n/a | 432K | 3.4M | -3.4M | -1.5M | 1.35K | -15.84M | 15.84M | 4.15K | 6.31K | -1K | 4.55K | 2.18K | -1.64K |
Investing Cash Flow | -231K | -3.55M | 614K | 1.39M | 432K | 2.28M | -3.54M | 705K | 1.35M | 1.98M | 5.13M | 4.15M | 6.31M | 6.38M | 4.55M | 2.17M | -1.64M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -4.4M | 8.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 1.51M | 448K | 8.34M | n/a | n/a | n/a | 6.18M | n/a | n/a | n/a | 70K | n/a | n/a | n/a | n/a | n/a | 17.37M |
Net Cash Flow | 116K | -5.07M | 7.89M | 375K | -1.4M | 1.38M | 473K | -662K | -344K | -2.04M | 2.08M | -1.76M | 857K | -605K | -4.43M | -5.46M | 6.44M |
Free Cash Flow | -1.17M | -1.97M | -1.06M | -1.02M | -1.83M | -898K | -2.18M | -1.37M | -1.7M | -4.03M | -3.11M | -5.91M | -5.45M | -6.99M | -8.99M | -7.64M | -9.29M |